Joint Research Office
- What does the JRO do?
- Post Approval
- Academic Clinical Trials
- Commercial Research
- Training and Education
- Patient and Public Involvement
- Funding Opportunities
- JRO News
- Standard Operating Procedures
- Clinical Trials Units (CTUs)
© Sayandip Mukherjee.
Setting up a new study? What approvals do you need?
There are three main approval processes listed below that must be considered before conducting clinical research at UCL or UCLH. Please note this information applies to research only. If you are unsure whether or not your study is classified as research, click here for guidance.
The JRO largely supports researchers with the set-up of non-interventional studies, while UCL Clinical Trials Units (CTUs) will support researchers with
interventional studies. Click here for more information. If you are unsure whether your study is interventional, contact
a JRO research coordinator by emailing email@example.com
All research requires a sponsor to take on responsibility for the design and management of a study. The sponsor will usually be the Chief Investigator's employing organisation, the lead organisation providing health or social care, or in some cases the main funder. UCL and UCLH both act as a Sponsor for studies. The JRO works with researchers to ascertain which organisation should act as the sponsor.
2. Regulatory approvals
Most studies will need to be reviewed by a Research Ethics Committee (REC). Approvals from other regulatory bodies such as The Medicines and Healthcare Products Regulatory Agency may be required. The JRO can help researchers prepare applications for REC and other approval bodies.
3. NHS Permission
Research recruiting UCLH patients or staff and/or taking place on UCLH premises will require NHS permission (often referred to as R&D approval). It is a condition of Research Ethics Committee approval that NHS Permission is obtained before a study starts at a particular site. The JRO acts for UCLH as a Permission Centre, and may issue NHS Permission for your study.
The decision about which institute should sponsor a study is made while a study proposal is being prepared for regulatory approval. Which institute will act as sponsor is determined by the nature of the study. The JRO or one of UCL’s Clinical Trials Units can help with this.
UCL or UCLH will sponsor studies, providing the investigator has a substantive or honorary contract with the institution and that adequate peer review and funding is in place. A sponsorship decision is based on risk. UCLH will generally be named as a sponsor for studies deemed to be low risk, whereas UCL will take on higher risk studies.
To find out whether your study needs REC approval, you will need to consult your sponsor. Alternatively you can visit the Health Research Authority website for NHS research guidance or UCL REC for non-NHS research.
To find out if other approvals from bodies such as The Medicines and Healthcare Products Regulatory Agency are needed, consult your sponsor.
There are three routes to obtaining NHS permission from the JRO. Please choose the relevant information below based on the nature of your study.
As part of the Harmonisation
process, one of four Permission
Centres will process and issue
NHS Permission for a study to take place at UCLH, depending on disease area.
here to see which Permission Centre
your study would be reviewed by.
Please note that 'Harmonisation' applies to all commercially sponsored studies and to non-commercially sponsored studies proceeding through NIHR portfolio adoption only.
Process for obtaining NHS Permission:
Documents that need to be submitted for review:
Please contact the JRO or use the links below to obtain more information.
Queries regarding Commercial Harmonisation: Harmonis@uclh.nhs.uk
Queries regarding Non-commercial Harmonisation: Ncharm@uclh.nhs.uk
General Non-NHS research queries: JRO.RandD@ucl.ac.uk
All other research related queries: RandD@uclh.nhs.uk